Area Development
Cargill's Diamond V, a leading global animal health business, completed a $29.1 million, 100,000 square foot expansion, at its manufacturing plant in Cedar Rapids, Iowa. The project will enable the company to complete all production and packaging of its natural immune support products in one facility.

According to company officials, “Food customers and consumers are increasingly interested in understanding how animals are being raised, and demand is rising for animal protein that has been produced in natural and sustainable ways.”

"Diamond V has always been committed to offering products that support healthy animals, more efficient animal production, better pre-harvest food safety, stronger antibiotic stewardship, and improved public health," said Mike Goble, Cargill's global managing director for Diamond V. "The demand for natural animal health products is growing, and this expansion will allow us to support our customers."

"Cedar Rapids is a proud manufacturing and agriculture-based community, and few companies better represent those two important industries than Diamond V and Cargill," said Cedar Rapids Mayor Brad Hart. "Diamond V is a global leader in science, nutrition and health, and we appreciate Cargill's commitment to building and expanding this important business in our community."

As a result of this expansion, scheduled to begin production in February, Diamond V will close its north plant and transfer all 20 employees to the south facility. The expansion immediately adds two production lines and is large enough to house up to eight production lines as the business grows to meet rising consumer and customer demand.

In 2018, Cargill acquired Diamond V, creating a leading natural animal health and nutrition business. The acquisition accelerated growth and supports healthier animals and more wholesome food production in the $20 billion global animal feed additives market. In response to the rising importance of health among both farmers and consumers, Cargill Health Technologies was formed in 2019, demonstrating Cargill's continued commitment to growing a leading digestive and immune health business for both animal and human application.

"Through Cargill Health Technologies, we are pioneering a new path and unlocking the full potential of the bodies we nourish, helping both people and animals live more healthy days," said Chuck Warta, President, Cargill Health Technologies. "When we put the full muscle of Cargill behind it, we believe we can address some of the most pressing global problems in how to feed the world in a safe, responsible and sustainable way."